• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mucosal delivery of a combination adjuvant comprising emulsified fine particles and LD-indolicidin enhances serological immunity to inactivated influe

tetano

Editor, Senior Moderator
Microbes Infect. 2016 Jul 7. pii: S1286-4579(16)30090-9. doi: 10.1016/j.micinf.2016.06.007. [Epub ahead of print]
[h=1]Mucosal delivery of a combination adjuvant comprising emulsified fine particles and LD-indolicidin enhances serological immunity to inactivated influenza virus.[/h] Huang MH[SUP]1[/SUP], Dai SH[SUP]2[/SUP], Chong P[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Here we investigate the immunogenicity of a combination adjuvant comprising emulsified fine particles (namely PELC) together with LD-indolicidin, a peptiomimetic stereoisomer of the bovine neutrophil peptide indolicidin. We demonstrated that intranasal either PELC/LD-indolicidin or Alum enhances protective influenza-specific serological immunity in mice; however, the adjuvant potency of Alum was rather reduced when the mice vaccinated orally with formulated influenza vaccines. The information gathered from this study will enhance our effort in the formulation design as well as the optimization of alternative administration routes for prophylactic vaccines against emerging infectious diseases, in particular pandemic influenza.
Copyright ? 2016. Published by Elsevier Masson SAS.


[h=4]KEYWORDS:[/h] Combination adjuvant; Host defense peptides; Mucosal vaccine; Vaccine delivery systems

PMID: 27394146 DOI: 10.1016/j.micinf.2016.06.007
[PubMed - as supplied by publisher]
 
Back
Top Bottom